Aerosol delivery

P. Diot (Tours, France)

Source: Annual Congress 2013 –PG4 How to build an experimental animal lung lab
Session: PG4 How to build an experimental animal lung lab
Session type: Postgraduate Course
Number: 63

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Diot (Tours, France). Aerosol delivery. Annual Congress 2013 –PG4 How to build an experimental animal lung lab

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Aerosol delivery overview
Source: Annual Congress 2010 - The essentials of aerosol therapy: what the practicing physician should know
Year: 2010

Validation of monodisperse corticosteroid aerosols for in-vivo delivery
Source: Annual Congress 2008 - Investigation, inspiration, ventilation, dedication: the essence of physiological measurement
Year: 2008


Lung deposition of 99mTc-DTPA delivered with an adaptive aerosol delivery system
Source: Eur Respir J 2007; 30: Suppl. 51, 545s
Year: 2007

Comparison of aerosol delivery from two inhaler technique-guidance devices.
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018


Effect of device and formulation on delivery of budesonide suspensions by nebulizers
Source: Eur Respir J 2002; 20: Suppl. 38, 542s
Year: 2002

Successful conversion of patients using nebulised iloprost from multisonic nebuliser to adaptive aerosol delivery nebuliser
Source: Eur Respir J 2007; 30: Suppl. 51, 345s
Year: 2007

Bench performance and lung deposition of the I-neb adaptive aerosol delivery system
Source: Annual Congress 2007 - New developments in thoracic imaging modalities and illustrated thorax pathologies
Year: 2007


Surgical facemask affects fugitive emissions during aerosol drug delivery by high-flow nasal therapy
Source: Virtual Congress 2021 – COVID-19 and acute respiratory failure
Year: 2021


Aerosol characteristics of a unique breath-actuated nebulizer
Source: International Congress 2017 – Lung function practice in daily life
Year: 2017


Aerosol delivery aspects within a high-flow therapy system in COPD patients
Source: ERJ Open Res, 7 (1) 00422-2020; 10.1183/23120541.00422-2020
Year: 2021



Air and particle dispersion during oxygen delivery via a simple mask
Source: Eur Respir J 2006; 28: Suppl. 50, 732s
Year: 2006

Aerosol delivery characteristics from a new jet nebulizer in comparison with commercially available jet nebulizers
Source: Annual Congress 2008 - Wheezing in preschool children
Year: 2008

Investigation of Beclason efficiency in new delivery device Easi-breathe
Source: Eur Respir J 2002; 20: Suppl. 38, 499s
Year: 2002

Compared Aerosol Drug Delivery Efficacy of Two Types Nebulizer in Adult Mechanical Ventilator
Source: International Congress 2017 – Pulmonary drug and devices delivery
Year: 2017


Characterization of the performance of a new portable jet nebulizer system for the delivery of budesonide suspension for nebulization
Source: Annual Congress 2008 - Wheezing in preschool children
Year: 2008

Aerosol performance of two ambroxol inhalation products upon nebulisation by the eFlow rapid
Source: Eur Respir J 2006; 28: Suppl. 50, 212s
Year: 2006

Reduction of treatment time for nebulized treatments using a new adaptive aerosol delivery mode
Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy
Year: 2008

Feasibility of less invasive surfactant administration (LISA) in the delivery suite
Source: Virtual Congress 2020 – Neonatal and paediatric intensive care: diagnosis, management and outcomes
Year: 2020